These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 9392584)
1. SMI-31 immunoreactivity in inclusion body myositis. Spuler S; Engel AG Ann Neurol; 1997 Nov; 42(5):815. PubMed ID: 9392584 [No Abstract] [Full Text] [Related]
2. [Is inclusion body myositis a true myositis?]. Serratrice G Rev Rhum Ed Fr; 1993 Mar; 60(3):187-8. PubMed ID: 8293003 [No Abstract] [Full Text] [Related]
3. High dose immunoglobulin therapy in a case of inclusion body myositis: clinical and immunologic aspects. Salvarani C; Boiardi L; Maldini MC; Mancini R; Rinaldi M; Macchioni P; Portioli I J Rheumatol; 1993 Aug; 20(8):1455-6. PubMed ID: 8230050 [No Abstract] [Full Text] [Related]
14. beta-Amyloid protein immunoreactivity in muscle of patients with inclusion-body myositis. Askanas V; Engel WK; Alvarez RB; Glenner GG Lancet; 1992 Feb; 339(8792):560-1. PubMed ID: 1346915 [No Abstract] [Full Text] [Related]
15. Inclusion body myositis. Mendell JR; Sahenk Z Neurology; 1992 Nov; 42(11):2231-2. PubMed ID: 1279467 [No Abstract] [Full Text] [Related]
16. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672 [TBL] [Abstract][Full Text] [Related]
17. Inclusion body myositis associated with hepatitis C virus infection. Tsuruta Y; Yamada T; Yoshimura T; Satake M; Ogata K; Yamamoto T; Furuya H; Kira J Fukuoka Igaku Zasshi; 2001 Nov; 92(11):370-6. PubMed ID: 11774706 [TBL] [Abstract][Full Text] [Related]
18. Affinity binding of inclusion bodies on supermacroporous monolithic cryogels using labeling with specific antibodies. Ahlqvist J; Kumar A; Sundström H; Ledung E; Hörnsten EG; Enfors SO; Mattiasson B J Biotechnol; 2006 Mar; 122(2):216-25. PubMed ID: 16442653 [TBL] [Abstract][Full Text] [Related]
19. [Inclusion bodies of human cytomegalovirus are composed of the DNA and immediately early and early antigens of the virus]. Yan QG; Huang GS; Guo Y; Wang Z; Feng JL; Yang GR Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):262-5. PubMed ID: 15340573 [TBL] [Abstract][Full Text] [Related]
20. Expression, purification, and in vitro refolding of a humanized single-chain Fv antibody against human CTLA4 (CD152). Chen LH; Huang Q; Wan L; Zeng LY; Li SF; Li YP; Lu XF; Cheng JQ Protein Expr Purif; 2006 Apr; 46(2):495-502. PubMed ID: 16243538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]